Tony Cárdenas actually said...

when it comes to the cost of doing business versus the life of a child, no comparison, in my opinion. Absolutely none.

I was impressed to learn that Kaiser Permanente has taken such a leading stance on biosimilar utilization.

Biosimilars hold the potential to help cut down these costs with marketed biosimilars being priced an average of 40 percent less than the bi...

I hope that the Americans are watching because 1 out of every $5 in Americans' wallets somehow some way goes back into their healthcare need...